Chile received the first batch of vaccines from Oxford on Friday (23) Govit-19, It will only be used for men on your healthcare recommendation.
The cargo was received by Health Minister Enrique Paris with a dose of 158,400. “This is the first vaccine to come under the Kovacs agreement,” said the Minister of the World Health Organization (WHO).
Chile is one of the fastest growing countries in the vaccine process. Out of a total of 19 million, about 7.9 million people have been vaccinated with at least one dose.
The Oxford vaccine is controversial, mainly in Europe, due to the rare occurrence of diagnosed blood clots, especially due to fears that develop in women.
On Friday, the European Medicines Institute (EMA)’s review of the vaccine showed that its benefits increase with age and outweigh the risks.
Last week, the Chilean Public Health Organization (ISP), which gave emergency approval for the vaccine, recommended its use in women over 55 and men over 18.
Based on the recommendation, Deputy Secretary of Health Paula Dasa announced Friday that “all men who follow the calendar starting next week will receive the Oxford vaccine, which will only be given to men.”
The first dose is administered 12 weeks after the first dose.
Meanwhile, the health minister said he was examining the portfolio, including pregnant women, in the vaccination program. “When we have all the scientific information, it will start soon,” he said.
For pregnant women, the Pfizer vaccine will be selected, which will be used in Chile in conjunction with Coronavac from the Chinese laboratory Sinovac, Paris added.